loading

Halozyme Therapeutics Inc 주식(HALO)의 최신 뉴스

pulisher
02:32 AM

How many analysts rate Halozyme Therapeutics Inc. as a “Buy”Track top-performing stocks effortlessly - jammulinksnews.com

02:32 AM
pulisher
02:14 AM

What analysts say about Halozyme Therapeutics Inc. stockDiscover stock picks with superior returns - jammulinksnews.com

02:14 AM
pulisher
Aug 02, 2025

What catalysts could drive Halozyme Therapeutics Inc. stock higher in 2025Unmatched profit potential - jammulinksnews.com

Aug 02, 2025
pulisher
Jul 31, 2025

Alnylam, Halozyme among latest firms to win EU backing for drugs - MSN

Jul 31, 2025
pulisher
Jul 30, 2025

Halozyme Therapeutics Insider Lowered Holding By 38% During Last Year - 富途牛牛

Jul 30, 2025
pulisher
Jul 30, 2025

Morgan Stanley Maintains a Hold on Halozyme Therapeutics (HALO) With a $62 PT - MSN

Jul 30, 2025
pulisher
Jul 29, 2025

How Halozyme Therapeutics Inc. stock performs during market volatilitySmart Money Tracking Signal Generator Activated - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Short Interest Drops in Halozyme Therapeutics Inc. After RallyOversold Recovery Opportunity Stocks Attract Buyers - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Halozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy? - Yahoo Finance

Jul 29, 2025
pulisher
Jul 29, 2025

Halozyme Therapeutics Inc. Outperforms Peers on Volume MetricsPrice Action Based Buy Opportunity List Published - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Why Halozyme Therapeutics Inc. stock attracts strong analyst attentionProfit Target Stock Opportunity Monitor Activated - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

How Resilient Is Halozyme Therapeutics Inc. Stock During Economic DownturnsMarket Entry and Exit Point Tips From Traders - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-28 01:53:45 - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Does Halozyme Therapeutics Inc. stock perform well during market downturnsBuild a strong portfolio for growth and safety - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What is Halozyme Therapeutics Inc. company’s growth strategyOutstanding capital returns - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 25, 2025

Halozyme’s Promising Cancer Study: A Potential Game-Changer in Oncology - TipRanks

Jul 25, 2025
pulisher
Jul 25, 2025

Should I buy Halozyme Therapeutics Inc. stock before earningsRecord-setting profit potential - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What risks could impact Halozyme Therapeutics Inc. stock performanceConsistently superior profits - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

38% Of This Halozyme Therapeutics Insider's Holdings Were Sold - simplywall.st

Jul 24, 2025
pulisher
Jul 24, 2025

Is Halozyme Therapeutics Inc. stock overhyped or has real potentialBreakout profit opportunities - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Halozyme to Report Second Quarter 2025 Financial and Operating Results - Eastern Progress

Jul 24, 2025
pulisher
Jul 23, 2025

BlackRock, Inc. Adjusts Holdings in Halozyme Therapeutics Inc. - GuruFocus

Jul 23, 2025
pulisher
Jul 23, 2025

Halozyme Therapeutics Inc. Stock Analysis and ForecastExceptional profit margins - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Halozyme Therapeutics Says Myeloma Drug With Enhanze Delivery Technology Gets EU Approval - 富途牛牛

Jul 23, 2025
pulisher
Jul 23, 2025

Is Halozyme Therapeutics Inc. a good long term investmentFree Risk Assessment Services - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

J&J Darzalex injectable cleared in EU for smouldering MM (JNJ) - Seeking Alpha

Jul 23, 2025
pulisher
Jul 23, 2025

Halozyme says EU approves new indication for Janssen’s Darzalex Faspro - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

Breakthrough: EU Approves DARZALEX Faspro as First-Ever Treatment for Early-Stage Multiple Myeloma - Stock Titan

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Halozyme Therapeutics Inc. stock priceFree Stock Market Real-Time Monitoring - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Why Halozyme Therapeutics (HALO) is Poised to Beat Earnings Estimates Again - Yahoo Finance

Jul 22, 2025
pulisher
Jul 22, 2025

Here's Why Halozyme Therapeutics (HALO) is a Strong Growth Stock - Yahoo Finance

Jul 22, 2025
pulisher
Jul 22, 2025

Halozyme to Present Q2 2025 Financial Results After Market Close on August 5 - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

Halozyme Stock Maintains Hold Rating Amid CMS Pricing Uncertainty and Regulatory Concerns. - AInvest

Jul 22, 2025
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
자본화:     |  볼륨(24시간):